Bakrieland Development Tbk. vs Merck Tbk. — how do they compare? Bakrieland Development Tbk. trades at Rp22 (market cap 957.48B, 12.03M 24h volume), while Merck Tbk. trades at Rp3,860 (market cap 1.7T, 28K 24h volume). The key difference: Merck Tbk. is the larger of the two by market cap, and Bakrieland Development Tbk. is more actively traded (12.03M versus 28K). Which is the better fit depends on your goals.
| ELTY | MERK | |
|---|---|---|
Market Cap | 957.48B | 1.7T |
Volume | 12.03M | 28K |
Lot | 120.35K | 280 |
Turnover | 264.77M | 107.47M |
Average Price | 22 | 3,838.25 |
Value | 264.77M | 107.47M |
Indicative Equilibrium Price | 22 | 3,850 |
Indicative Equilibrium Volume | 35.79K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bakrieland Development Tbk. (“The Company”) was established with Notarial Deed No. 209 of John Leonard Waworuntu, S.H., dated June 12, 1990. The Company's articles of association have been amended several times, among others, the changes of the Company's name from PT Elang Realty (formerly PT. Purilestari Indah Pratama) Tbk. to PT Bakrieland Development Tbk. which have been notarized by Notarial Deed No. 29 of Harun Kamil, S.H., dated April 3, 1997.
Read more on ELTY →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →